血压正常胎儿生长受限的胎盘转录与组织学亚型与子痫前期相似
本研究对20例血压正常小于胎龄儿(疑似胎儿生长受限)胎盘进行基因表达聚类和组织病理学评估,并与既往子痫前期队列(n=77)合并为97例样本分析。发现血压正常小于胎龄儿胎盘存在3种转录亚型,其中至少2种为病理性子痫前期样亚型,与高血压小于胎龄儿胎盘亚型高度相似。
要点
- 血压正常小于胎龄儿胎盘可分为3种转录亚型,临床与组织病理学特征各异。
- 其中2种亚型分别与子痫前期「经典型」和「免疫型」胎盘亚型高度相似。
- 另1种亚型胎盘病变轻微,可能代表体质性小婴儿或轻度胎儿生长受限。
核心结论
- 血压正常小于胎龄儿至少存在2种病理性胎盘病因,可能代表真正的胎儿生长受限。
- 这些亚型在基因表达和组织病理学上与既往鉴定的「经典型」和「免疫型」子痫前期胎盘亚型高度相似。
- 还发现1种胎盘病变轻微的血压正常小于胎龄儿(疑似胎儿生长受限)亚型,可能同时代表体质性小婴儿和轻度胎儿生长受限,但现有数据无法区分。
- 作者认为有必要开展未来工作,聚焦于针对胎儿生长受限各亚型的病因驱动生物标志物识别和治疗干预。
研究设计与样本
- 新数据集纳入20例血压正常小于胎龄儿(出生体重低于同孕龄同性别第10百分位)且疑似胎儿生长受限(超声提示胎盘功能不全)的胎盘,进行全基因组信使RNA表达评估和盲法详细组织病理学评估。
- 将这些样本与既往已发表的子痫前期队列(n=77)中的一部分样本合并,形成聚焦胎儿生长的聚合队列(n=97),包含血压正常小于胎龄儿、高血压(子痫前期和慢性高血压)小于胎龄儿以及血压正常适于胎龄儿胎盘。
- 对基因表达数据进行无监督聚类,并将临床和组织病理学特征与识别出的样本聚类进行关联分析。
主要发现
- 聚合数据集聚类分析揭示了血压正常小于胎龄儿/疑似胎儿生长受限胎盘的3种转录亚型,临床和组织病理学发现存在差异富集。
- 第一亚型表现为无胎盘病变或轻度母体血管灌注不良病变,与健康适于胎龄儿对照受试者共聚类。
- 第二亚型显示更严重的缺氧损伤证据和母体血管灌注不良病变。
- 第三亚型显示免疫/炎症反应和母胎界面紊乱的组织学特征。
- 所有3种血压正常小于胎龄儿亚型均与一组高血压小于胎龄儿胎盘共聚类,后者临床结局更严重,但转录和组织病理学胎盘谱非常相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infants born small for gestational age because of pathologic placenta-mediated fetal growth restriction can be difficult to distinguish from those who are constitutionally small. Additionally, even among fetal growth-restricted pregnancies with evident placental disease, considerable heterogeneity in clinical outcomes and long-term consequences has been observed. Gene expression studies of fetal growth-restricted placentas also have limited consistency in their findings, which is likely due to the presence of different molecular subtypes of disease. In our previous study on preeclampsia, another heterogeneous placenta-centric disorder of pregnancy, we found that, by clustering placentas based only on their gene expression profiles, multiple subtypes of preeclampsia, including several with co-occurring suspected fetal growth restriction, could be identified. OBJECTIVE: The purpose of this study was to discover placental subtypes of normotensive small-for-gestational-age pregnancies with suspected fetal growth restriction through the use of unsupervised clustering of placental gene expression data and to investigate their relationships with hypertensive suspected fetal growth-restricted placental subtypes. STUDY DESIGN: A new dataset of 20 placentas from normotensive small-for-gestational-age pregnancies (birthweight <10th percentile for gestational age and sex) with suspected fetal growth restriction (ultrasound features of placental insufficiency) underwent genome-wide messenger RNA expression assessment and blinded detailed histopathologic evaluation. These samples were then combined with a subset of samples from our previously published preeclampsia cohort (n=77) to form an aggregate fetal growth-focused cohort (n=97) of placentas from normotensive small-for-gestational-age, hypertensive (preeclampsia and chronic hypertensive) small-for-gestational-age, and normotensive average-for-gestational-age pregnancies. Gene expression data were subjected to unsupervised clustering, and clinical and histopathologic features were correlated to the identified sample clusters. RESULTS: Clustering of the aggregate dataset revealed 3 transcriptional subtypes of placentas from normotensive small-for-gestational-age/suspected fetal growth-restricted pregnancies, with differential enrichment of clinical and histopathologic findings. The first subtype exhibited either no placental disease or mild maternal vascular malperfusion lesions, and, co-clustered with the healthy average-for-gestational-age control subjects; the second subtype showed more severe evidence of hypoxic damage and lesions of maternal vascular malperfusion, and the third subtype demonstrated an immune/inflammatory response and histologic features of a maternal-fetal interface disturbance. Furthermore, all 3 of these normotensive small-for-gestational-age subtypes co-clustered with a group of placentas from hypertensive small-for-gestational-age pregnancies with more severe clinical outcomes, but very comparable transcriptional and histologic placental profiles. CONCLUSION: Overall, this study provides evidence for at least 2 pathologic placental causes of normotensive small-for-gestational-age, likely representing true fetal growth restriction. These subtypes also show considerable similarity in gene expression and histopathology to our previously identified "canonical" and "immunologic" preeclampsia placental subtypes. Furthermore, we discovered a subtype of normotensive small-for-gestational-age (with suspected fetal growth restriction) with minimal placental disease that may represent both constitutionally small infants and mild fetal growth restriction, although these cannot be distinguished with the currently available data. Future work that focuses on the identification of etiology-driven biomarkers and therapeutic interventions for each subtype of fetal growth restriction is warranted.
引用
- Gibbs I, Leavey K, Benton SJ, et al. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia. Am J Obstet Gynecol. 2018. PMID: 30312585. doi:10.1016/j.ajog.2018.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。